FOXO1 and G9a have a potential pathological and clinical relevance, as it has been observed that FOXO1 protein levels are reduced and G9a protein levels elevated in human colon cancer patient specimens38. The gene discussed is EHMT2; the disease is malignant colon neoplasm.